“The next new £1bn UK stock will be…”

Three of The Motley Fool UK’s contract authors put forward their case for the next UK stock to see its market cap soar past the £1bn threshold!

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

British union jack flag and Parliament house at city of Westminster in the background

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Recently, we asked our free-site writers to propose the US companies they think will be next to exceed $1trn in market cap. Now, it’s the turn of UK stocks — which will be next to cross the £1bn line?

Advanced Medical Solutions

What it does: AMS designs, develops, and manufactures innovative tissue-healing technology and wound-care. Previous highest market cap: c.£900m.

By Dr James Fox. Advanced Medical Solutions Group (LSE:AMS) develops and sells wound treatment products that help repair and close up damaged and cut tissue during and after surgery. These products are distributed in 80 countries around the world.

The Cheshire firm is a well-run, cash generative business with strong positioning in end markets. These positions will likely be enhanced by some exciting launches including LiquiBandFix8 – a cyanoacrylate adhesive designed to fix mesh to tissue inside the body.

I’m also anticipating increasing demand. With large elective procedure backlogs around the world, wound treatment products will likely experience a tailwind in the coming years.

Inflation is an issue, but in its full-year review the company said it had adjusted pricing accordingly. More adjustment may be required.

With a market cap just over £501m, it’s got some way to go to reach £1bn. But I’m channelling my inner Warren Buffett, It’s a quality company, and I believe it’s discounted at just 20x earnings.

Dr James Fox does not own shares in Advanced Medical Solutions Group

Yellow Cake 

What it does: Yellow Cake holds and trades uranium which it acquires from Kazatomprom, one of the world’s biggest producers. Previous highest market cap: £914m

By Royston Wild. Nuclear energy remains an unpopular sector for many share pickers. But as the world moves away from fossil fuels, stocks that supply radioactive fuel might have as much investment potential as renewable energy shares. 

This is where Yellow Cake (LSE:YCA) comes in. It holds and trades uranium, a commodity for which demand is tipped to soar as construction of new nuclear reactors booms.  

There are currently 440 reactors in operation today, according to the World Nuclear Association, and another 60 in construction. The International Energy Agency reckons global nuclear capacity will soar 42% between 2020 and 2050. 

Buying shares in this UK stock has one clear advantage over investing in a uranium producer. This is because it doesn’t expose shareholders to exploration, mine development, or production risks that can be devastating for returns. 

On the other hand, war in Ukraine poses an ongoing threat to Yellow Cake. This is because the material it acquires from Kazakhstan is shipped through Russia, leaving it vulnerable to potential supply problems.

But the nuclear industry has so far been unaffected, and on balance I think the potential rewards of owning this UK share outweigh the dangers.

Royston Wild does not own shares in Yellow Cake. 

Yellow Cake

What it does: Yellow Cake buys and stores physical uranium and looks to exploit opportunities arising from this.

By Paul Summers: I’ve been watching the rise of Yellow Cake (LSE: YCA) with interest. The share price has now doubled in five years.

Recent gains can be linked to Russia’s invasion of Ukraine. The concern is that the former – a leader in uranium conversion and enrichment – will now stop trading with Western nations. This could make the metal more expensive at a time when attitudes toward nuclear energy are improving thanks to the relatively small amount of waste it produces.

To be clear, this is not a stock for widows and orphans. Investors steered clear of uranium for a decade following the Fukushima nuclear plant accident in 2012.

Yellow Cake doesn’t pay a dividend either.

Considering that the UK stock’s marlet cap now stands at £835m, however, I think there’s a good chance the company’s valuation eventually passes the £1bn threshold if, as expected, demand begins to outstrip supply.

Paul Summers has no position in Yellow Cake

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

The Motley Fool UK has recommended Advanced Medical Solutions Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Top Stocks

Top Stocks

4 stocks Fools love with a long history of increasing dividends

Familiar with REITs? You may want to be after reading this, with two of the four dividend stocks falling under…

Read more »

Mother and Daughter Blowing Bubbles
Investing Articles

5 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Top Stocks

5 stocks that Fools have recently sold

Three complete exits and one partial sale of a shareholding -- why did these five Fools sell these particular UK-listed…

Read more »

British Pennies on a Pound Note
Investing Articles

3 penny stocks Fools actually love for the long term!

Many speculate on which penny stocks might rapidly soar in price. But it’s worth reiterating that our favourite holding period…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

Best US stocks to consider buying in May

We asked our freelance writers to reveal the top US stocks they’d buy in May, which included a cybersecurity leader…

Read more »

Bearded man writing on notepad in front of computer
Investing Articles

Best British growth stocks to consider buying in May

We asked our freelance writers to reveal the top growth stocks they’d buy in May, which included a Share Advisor…

Read more »

Entrepreneur on the phone.
Investing Articles

Best British stocks to consider buying in May

We asked our writers to share their ‘best of British’ stocks to buy this month, including a broadcaster and a…

Read more »

Young black woman in a wheelchair working online from home
Investing Articles

7 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »